Anne Koy, Jean-Pierre Lin, Terence D Sanger, Warren A Marks, Jonathan W Mink, Lars Timmermann, The Lancet Neurology, Volume 15, Issue 7, June 2016, Pages 719-735, ISSN 1474-4422, doi:10.1016/S1474-4422(16)00132-0
Movement disorders in children are causally and clinically heterogeneous and present in a challenging developmental context. Treatment options are broad ranging, from pharmacotherapy to invasive neuromodulation and experimental gene and stem cell therapies.It is vital to transfer the expanding knowledge of the movement disorders into the development of novel symptomatic or, ideally, disease-modifying treatments, and to assess these therapeutic strategies in appropriately designed and well done trials.
Wednesday, May 11, 2016
Subscribe to:
Posts (Atom)
